Damien McDevitt is the founder of Aspen Neuroscience. Aspen Neuroscience has raised $340M in total funding. Latest round: Series C.
Damien McDevitt, PhD, is the President, Chief Executive Officer, and Board Member of Aspen Neuroscience, a clinical-stage biotechnology company focused on autologous regenerative therapies for Parkinson's disease. He leads the company's efforts in personalized cell therapy, including the development of ANPD001 (Sasineprocel). McDevitt also works as a Board Advisor and Biotech Strategist in the biotechnology sector.
Full founder directory · Investor directory · Company funding database · Fundraising library